Ultragenyx’s Setrusumab falls short in Phase 3 osteogenesis imperfecta trials
The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates
The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates
Motiva, SmoothSilk, Round and Ergonomix implants represent the latest in plastic surgery innovation
ICC is a highly aggressive liver cancer arising from the intrahepatic biliary epithelium
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
Applications include detailed scientific rationale and supporting clinical evidence
The interim efficacy readout, involving around 170 participants with 15-month data, remains on track for the end of March 2026
The study met its primary endpoint with flying colors
CIRRUS-HCM, an open-label, multi-part study, evaluates EDG-7500 in patients with obstructive and nonobstructive HCM
Despite some promising subgroup signals, the company indicated it will not pursue further psychiatric trials
CX-5461 is “the world's first and most advanced G-quadruplex (G4) stabilizer in development
Subscribe To Our Newsletter & Stay Updated